The Elgan-2 Research Study (Extremely low gestational age newborns) - Neonatal Biomarkers in Extremely Preterm Babies Predict Childhood Brain Disorders
What are we studying?
The primary aim is test the hypothesis that children with elevated concentrations of
inflammation-associated biomarkers in the blood in the highest quartile during the first 2 postnatal weeks, as compared to those without such elevations, have general cognitive ability deficits at 9 years.
Who can participate?
Children who enrolled in the preceding Elgan-1 Study.
How will participants be compensated?
Compensation will be provided of offset estimated transportation cost.
For more information, contact CANDI at 774-455-4100 or ChildResearch@umassmed.edu.
Docket # 14398
Investing in the future...helping kids and families.